Japanese encephalitis vaccine (live, attenuated) Completed Phase 4 Trials for Japanese Encephalitis Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02514746Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose
NCT01981967Post-licensure Safety Study of IMOJEV® in Thailand